Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • WELL vs MRNA✓SelectedUSD · MRNAWELL vs MRNA performance historyLatest closeAs of-1.64%11/19
Stock and ETF performance explorer

WELL vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+224.4%
MRNA return
-24.9%
Excess return
+249.3%
Maximum drawdown
-40.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.6%+1.3%-2.9%-1.7%
7D-0.7%-13.8%+13.1%-0.6%
30D+2.5%-17.7%+20.2%+2.7%
3M+3.5%+14.3%-10.8%+3.2%
6M+12.4%+336.0%-323.6%+8.8%
YTD+32.9%+575.9%-543.0%+26.2%
1Y+25.3%+724.4%-699.1%+18.0%
3Y+193.6%+160.8%+32.9%+184.5%
5Y+224.4%-24.4%+248.8%+211.8%
All+224.4%-24.9%+249.3%+211.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling